These findings demonstrate that PLCH1 is highly expressed in breast cancer tissues and cell lines and is strongly associated with poor survival outcomes, highlighting its potential as a prognostic biomarker and therapeutic target in breast cancer. The gene discussed is PLCH1; the disease is breast cancer.